Guidance Model of Standardized Treatment of Antidepressants in Bipolar Disorder
NCT ID: NCT03148535
Last Updated: 2017-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
100 participants
INTERVENTIONAL
2017-06-01
2018-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antidepressant Treatments and Cognitive Function of Bipolar Patients
NCT04564573
Bipolar II Depression: Lithium, SSRI, or the Combination
NCT00276965
A Study of JNJ-55308942 in the Treatment of Bipolar Depression
NCT05328297
Observation Study of the Clinical Management of Bipolar Disorder
NCT01770704
Combination of Dextromethorphan and Memantine in Treating Bipolar Disorder
NCT03039842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lithium carbonate
recieve lithium carbonate
Lithium Carbonate
bipolar depression recieve lithium Carbonate treatment
lithium carbonate combined with SSRI antidepressant treatment
recieve lithium carbonate combined with SSRI antidepressant treatment
lithium carbonate combined with SSRI antidepressant treatment
lithium carbonate combined with SSRI antidepressant treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lithium Carbonate
bipolar depression recieve lithium Carbonate treatment
lithium carbonate combined with SSRI antidepressant treatment
lithium carbonate combined with SSRI antidepressant treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Si Tianmei
Clinical Psychopharmacology Division Institute of Mental Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of mental health, Peking University
Beijing, Beijing Municipality, China
The first hospital of Hebei Province University
Shijiazhuang, Hebei, China
Nanjing Brain Hospital
Nanjing, Jiangsu, China
Dalian No.7 People's Hospital
Dalian, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xueyi Wang, Professor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-1-4111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.